Article
Generation of an induced pluripotent stem cell line, ICGi014-A, by reprogramming peripheral blood mononuclear cells from a patient with homozygous D90A mutation in SOD1 causing Amyotrophic lateral sclerosis.
Stem cell research - 1 Jan 2020
Ustyantseva E I, Medvedev S P, Vetchinova A S, Illarioshkin S N, Leonov S V, Zakian S M
Abstract excerpt
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by death of motor neurons. To date, neither etiology nor pathogenesis of ALS are known, which leads to the absence of an effective treatment strategy. ALS patient-specific induced pluripotent stem cells (iPSCs) represent an excellent tool for the disease study. We obtained iPSCs line from peripheral blood mononuclear cells of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.